Serum Cholinesterases, a Novel Marker of Clinical Activity in Inflammatory Bowel Disease: A Retrospective Case-Control Study

Bibliographic Details
Title:	Serum Cholinesterases, a Novel Marker of Clinical Activity in Inflammatory Bowel Disease: A Retrospective Case-Control Study
Authors:	Xiaona Shao, Lei Yang, Keyue Hu, Ruiwei Shen, Qunqun Ye, Xiaogang Yuan, Qiang Zhao, Jianwei Shen
Source:	Mediators of Inflammation, Vol 2020 (2020)
Publisher Information:	Hindawi Limited, 2020.
Publication Year:	2020
Collection:	LCC:Pathology
Subject Terms:	Pathology, RB1-214
More Details:	Background. The aim of our study was to investigate whether serum cholinesterase (ChE) levels were associated with inflammatory bowel disease (IBD). Materials and Methods. We conducted a retrospective case-control study to clarify the relationship between serum ChE levels and IBD that included 142 patients with ulcerative colitis (UC), 60 patients with Crohn’s disease (CD), and 264 healthy controls (HCs). We used ROC curves to evaluate the diagnostic value of serum ChE levels for IBD. Results. Substantially lower serum ChE levels were detected in patients with UC than in HCs (6376 U/L versus 8418 U/L, P
Document Type:	article
File Description:	electronic resource
Language:	English
ISSN:	0962-9351 1466-1861
Relation:	https://doaj.org/toc/0962-9351; https://doaj.org/toc/1466-1861
DOI:	10.1155/2020/4694090
Access URL:	https://doaj.org/article/8cb9d647fe8a4ad288f64efdffddfa34
Accession Number:	edsdoj.8cb9d647fe8a4ad288f64efdffddfa34
Database:	Directory of Open Access Journals
Full text is not displayed to guests.	Login for full access.